Medication Data Sheet: List Of All Scheduled Medications And

Medication Data Sheet List All Scheduled Medicationsdrug Nameclassi

Medication Data Sheet - List all scheduled medications. Drug Name Classification, Normal Adult Dose, Route & Schedule Indications for Use and Expected Actions Side Effects/ Adverse Reactions Drug and Food Interactions Nursing Administration Considerations Client education & Evaluation of Medication Effectiveness Drug Name Classification Normal Adult Dose, Route Schedule

Paper For Above instruction

Introduction

Medication management remains a cornerstone of healthcare practice, ensuring that patients receive appropriate drug therapies for their medical conditions. A comprehensive medication data sheet serves as an essential reference for healthcare providers to administer, monitor, and educate patients effectively about their medications. This paper aims to systematically list scheduled medications, detailing critical aspects such as drug name, classification, dosage, administration route, indications, expected actions, side effects, drug-food interactions, nursing considerations, patient education, and evaluation of medication effectiveness.

Classification and Examples of Scheduled Medications

Scheduled medications are classified based on legal restrictions and potential for abuse and dependency. These classifications include Schedule I through V, with Schedule I drugs deemed to have no accepted medical use and high abuse potential (U.S. Drug Enforcement Administration, 2021). Common Schedule II medications include opioids like oxycodone and stimulants such as methylphenidate, whereas Schedule V drugs often consist of preparations with minimal controlled substances like cough preparations containing small amounts of codeine.

Medication Profiles

Below is a detailed overview of selected scheduled medications, encompassing their key characteristics:

1. Oxycodone (Schedule II)

- Classification: Opioid analgesic

- Normal Adult Dose: 10-20 mg every 4-6 hours, as needed

- Route & Schedule: Oral, around the clock or prn

- Indications for Use: Moderate to severe pain management

- Expected Actions: Binds to opioid receptors, altering pain perception

- Side Effects/Adverse Reactions: Respiratory depression, constipation, nausea, sedation

- Drug and Food Interactions: Enhanced sedation with CNS depressants; contraindicated with MAO inhibitors

- Nursing Considerations: Monitor respiratory status, administer with caution in hepatic impairment

- Client Education: Instruct on misuse risks, constipation prevention, and to avoid alcohol

- Evaluation of Effectiveness: Pain relief, improved activity tolerance

2. Methylphenidate (Schedule II)

- Classification: Central nervous system stimulant

- Normal Adult Dose: 10-60 mg/day in divided doses

- Route & Schedule: Oral, daily or divided doses

- Indications for Use: ADHD, narcolepsy

- Expected Actions: Increases dopamine and norepinephrine activity, improving focus

- Side Effects/Adverse Reactions: Insomnia, hypertension, decreased appetite, dependence

- Drug and Food Interactions: May interact with monoamine oxidase inhibitors, caffeine

- Nursing Considerations: Monitor for growth suppression in children, cardiovascular status

- Client Education: Emphasize adherence to dosing schedule, avoid abrupt cessation

- Evaluation of Effectiveness: Enhanced attention span, behavioral improvements

3. Diazepam (Schedule IV)

- Classification: Benzodiazepine anxiolytic

- Normal Adult Dose: 2-10 mg 2-4 times daily

- Route & Schedule: Oral, as prescribed

- Indications for Use: Anxiety, muscle spasms, seizures

- Expected Actions: Enhances GABA effects, producing sedative and anxiolytic effects

- Side Effects/Adverse Reactions: Drowsiness, dependency, respiratory depression

- Drug and Food Interactions: CNS depressants may potentiate effects

- Nursing Considerations: Monitor for dependence, avoid abrupt discontinuation

- Client Education: Warn against alcohol use, instruct on withdrawal risks

- Evaluation of Effectiveness: Reduced anxiety and muscle spasm, seizure control

4. Codeine (Schedule V)

- Classification: Opioid analgesic and antitussive

- Normal Adult Dose: 15-60 mg every 4-6 hours as needed

- Route & Schedule: Oral

- Indications for Use: Mild to moderate pain, cough suppression

- Expected Actions: Binds to opioid receptors to relieve pain or suppress cough

- Side Effects/Adverse Reactions: Drowsiness, constipation, nausea

- Drug and Food Interactions: Other CNS depressants, alcohol

- Nursing Considerations: Monitor for respiratory depression, gastrointestinal side effects

- Client Education: Caution about sleepiness, avoiding alcohol and operating machinery

- Evaluation of Effectiveness: Pain relief, cough suppression

5. Loratadine (Non-controlled, but included for comparison)

- Classification: Antihistamine

- Normal Adult Dose: 10 mg once daily

- Route & Schedule: Oral, daily

- Indications for Use: Allergic rhinitis, urticaria

- Expected Actions: Selectively antagonizes peripheral histamine H1 receptors

- Side Effects/Adverse Reactions: Headache, dry mouth, somnolence

- Drug and Food Interactions: Minimal significant interactions

- Nursing Considerations: Assess for allergic symptoms

- Client Education: Take as prescribed, acknowledge possible drowsiness

- Evaluation of Effectiveness: Relief of allergy symptoms

Conclusion

A detailed medication data sheet covering scheduled medications enhances safety, efficacy, and patient understanding. Recognizing the classification, appropriate dosing, routes, indications, expected actions, and potential side effects allows healthcare providers to optimize therapeutic outcomes. Furthermore, careful attention to drug interactions, nursing considerations, and patient education is vital to minimize adverse reactions and dependence risks. Regular assessment of medication effectiveness ensures adjustments are made promptly to meet individual patient needs.

References

  • U.S. Drug Enforcement Administration. (2021). Controlled Substances Schedules. https://www.deadiversion.usdoj.gov/schedules/
  • Goldfrank's Toxicologic Emergencies (11th ed.). (2019). McGraw-Hill Education.
  • Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2018). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill Education.
  • Katzung, B. G., Masters, S. B., & Trevor, A. J. (2018). Basic and Clinical Pharmacology (14th ed.). McGraw-Hill Education.
  • National Institute on Drug Abuse. (2020). Drugs, Brains, and Behavior: The Science of Addiction. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction
  • Centers for Disease Control and Prevention. (2022). Prescription Drug Monitoring Program. https://www.cdc.gov/drugmonitoring/index.html
  • Hollande, F., & Murphy, L. (2017). Medication safety: a guide for healthcare organizations. Journal of Patient Safety, 12(4), 345-352.
  • Schwartz, M. D., & Williams, T. (2019). Pharmacology and Therapeutics for Dentistry. Elsevier.
  • National Institute for Health and Care Excellence (NICE). (2016). Guide to the management of medications in clinical practice. NICE Publications.
  • World Health Organization. (2020). WHO Model List of Essential Medicines. https://www.who.int/publications/i/item/WMLE

Related Assignments